Order results by:
| Issue | Title | |
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
| Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| K. A. Gyamdzhyan, M. L. Maksimov | ||
| "... , angiotensin converting enzyme inhibitors and sartans, are compared. Data from evidence base of the both drug ..." | ||
| Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
| S. V. Nedogoda | ||
| "... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..." | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... The recent discussion about the dangers of using angiotensin-converting-enzyme (ACE) inhibitors ..." | ||
| Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
| D. B. Nebieridze, A. S. Safaryan | ||
| "... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..." | ||
| Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
| Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
| "... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..." | ||
| Vol 3, No 4 (2007) | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
| I. V. Szirov, E. V. Malichenko | ||
| "... Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most ..." | ||
| Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
| "... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..." | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| "... of sartans, not only as a drug with proven antihypertensive effect, but also in terms of their effects ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (ACE) inhibitors keep important ..." | ||
| Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
| E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
| "... and are gradually replacing angiotensin-converting enzyme inhibitors and sartans in CHF both without diabetes ..." | ||
| Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
| O. P. Shevchenko, А. О. Shevchenko | ||
| "... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..." | ||
| Vol 3, No 2 (2007) | OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina | ||
| "... dysfunction and atherogenesis. There are data that angiotensin converting enzyme inhibitor, zofenopril, has ..." | ||
| Vol 17, No 1 (2021) | A Clinical Case: the Risk Factors of Acute Kidney Injury in a Cardiological Patient | Abstract similar documents |
| E. A. Son, M. R. Kondratyuk, E. V. Fominykh, V. V. Fomin | ||
| "... -induced acute kidney injury in patients with cardiovascular disease, as well as discussing current views ..." | ||
| Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
| M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
| "... converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..." | ||
| Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
| D. A. Napalkov, E. N. Golovenko | ||
| Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| S. N. Tereshchenko, N. A. Dzhaiani | ||
| Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis ..." | ||
| Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute ..." | ||
| Vol 3, No 5 (2007) | EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
| L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov | ||
| "... Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy ..." | ||
| Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
| G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
| "... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors ..." | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... -Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... important mechanisms for the realization of the cardiovascular continuum. The role that angiotensin receptor ..." | ||
| Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
| E. A. Ryabikhin, M. E. Mozheiko | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..." | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... for different clinical situations are presented. Advantages and indications for combination of an angiotensin ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich | ||
| "... The quality of the database analysis that led to the conclusion that angiotensin converting enzyme ..." | ||
| Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
| "... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (ACE) inhibitor , on left ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (ACE) inhibitors ..." | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... and amlodipine, as the reference drug of angiotensin II receptor blockers and calcium channel blockers ..." | ||
| Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
| V. V. Fomin | ||
| "... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..." | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya | ||
| "... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... Aim. To evaluate the availability and affordability of medicines used to treat of cardiovascular ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... converting enzyme inhibitors, and in 42 cases (24.5%) angiotensin II receptor antagonists had been prescribed ..." | ||
| Vol 8, No 2 (2012) | TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..." | ||
| Vol 10, No 6 (2014) | IRBESARTAN IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... with single-pill combinations (SPCs) in majority patients with AH. Combination of the angiotensin II receptor ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..." | ||
| Vol 16, No 6 (2020) | Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery | Abstract similar documents |
| M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev | ||
| "... CoA reductase inhibitors and angiotensin-converting-enzyme (ACE) inhibitors/ angiotensin receptor ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... .8% – clopidogrel, 91.1% – anticoagulants, 91.6% – beta-blockers, 95.6% – statins, 94.2% – angiotensin-converting ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... . The frequency of taking angiotensin converting enzyme inhibitors in patients with cerebral stroke, statins ..." | ||
| Vol 16, No 6 (2020) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy | Abstract similar documents |
| N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva, S. Yu. Martsevich | ||
| "... than in the control group: angiotensin-converting-enzyme inhibitors/angiotensin receptor blockers (odds ..." | ||
| Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
| "... -converting enzyme type 1 gene (ACE1), rs5186 of angiotensin II type 1 receptor gene (ATP1), and rs1403543 ..." | ||
| Vol 3, No 2 (2007) | CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS | Abstract similar documents |
| V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina | ||
| "... – losartan 50-100 mg daily), 30 patients received neither ARA II nor angiotensin converting enzyme inhibitors ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| "... into account wide usage of non steroid antiinflammatory drugs calcium antagonists or angiotensin II receptor ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... -aldosterone system (an angiotensin-converting enzyme inhibitor [ACE inhibitor] or an angiotensin II receptor ..." | ||
| Vol 9, No 5 (2013) | PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| O. A. Shtegman | ||
| "... received target doses of ACE inhibitors/sartans and beta-blockers, respectively. Majority of CHF ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... kidney diseases (CKD) and the development of cardiovascular complications. Immune and non-immune ..." | ||
| Vol 3, No 5 (2007) | LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE | Abstract similar documents |
| N. P. Kutishenko, S. J. Martsevich | ||
| "... Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor ..." | ||
| Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... The high prevalence of arterial hypertension in association with high and very high cardiovascular ..." | ||
| Vol 5, No 5 (2009) | INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. V. Egorkina, V. M. Gorbunov, E. S. Abirova | ||
| "... in patients with arterial hypertension are presented. Advantages of angiotensin converting enzyme inhibitors ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... are actively discussed. Angiotensin-converting enzyme takes an active part in the BP control and vascular tone ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... risk and absence of compelling indications. Results. Angiotensin converting enzyme inhibitors (ACEI ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..." | ||
| Vol 14, No 5 (2018) | Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya | Abstract similar documents |
| T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova | ||
| "... Aim. To study the combined effect of cardiovascular risk factors and genetic markers that encode ..." | ||
| Vol 13, No 6 (2017) | FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES | Abstract similar documents |
| D. А. Napalkov, A. A. Sokolova | ||
| "... . Possible potentiating effect of angiotensin converting enzyme inhibitors and amlodipine is also discussed ..." | ||
| Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
| P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
| "... , angiotensin converting enzyme in-hibitors/angiotensin receptor blockers, beta-blockers. OMT aimed ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... into the outpatient REgistry of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..." | ||
| Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
| M. Loukianov | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
| "... are of great practical interest, as associative effect of angiotensin-converting enzyme inhibitors ..." | ||
| Vol 6, No 4 (2010) | LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... of "cardiovascular continuum". Changes in neurohumoral factors especially activation of the renin-angiotensin ..." | ||
| Vol 14, No 3 (2018) | CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... angiotensin converting enzyme inhibitors or angiotensin II receptor blockers. The follow-up duration was from ..." | ||
| Vol 13, No 4 (2017) | PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY | Abstract similar documents |
| O. M. Drapkina, D. U. Akasheva | ||
| "... and renin-angiotensin-aldosterone, is the basis of modern concepts of the pathogenesis of heart failure ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... drugs with nephroprotective properties are angiotensin-converting enzyme inhibitors and angiotensin II ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... Aim. To estimate antihypertensive, organ protective and metabolic efficiency of angiotensin ..." | ||
| Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... single-pill combinations is the combination of an angiotensin II receptor blocker and a calcium channel ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..." | ||
| Vol 3, No 3 (2007) | STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? | Abstract similar documents |
| R. G. Oganov, G. V. Pogosova | ||
| "... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..." | ||
| Vol 16, No 3 (2020) | Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations? | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova | ||
| "... data suggesting one of the first line reasonable combinations is the combination of angiotensin ..." | ||
| Vol 13, No 6 (2017) | ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina | ||
| "... mechanisms of the favorable impact of calcium channel blockers, as well as angiotensin-converting enzyme ..." | ||
| Vol 15, No 2 (2019) | How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... of different classes of drugs (beta-blockers, angiotensin-converting enzyme inhibitors, and new oral ..." | ||
| Vol 16, No 4 (2020) | Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist | Abstract similar documents |
| M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya | ||
| "... combinations today contain a renin-angiotensin system blocker (angiotensin converting enzyme inhibitors ..." | ||
| Vol 6, No 3 (2010) | THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova | ||
| "... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..." | ||
| Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
| Z M. Sizova | ||
| Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| S. A. Boytsov, I. P. Kolos | ||
| "... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... ) was associated with the prescription of anticoagulants, angiotensin-converting enzyme (ACE) inhibitors ..." | ||
| Vol 13, No 4 (2017) | CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva | ||
| "... The features of the pharmacokinetics of the angiotensin II receptor blocker telmisartan ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| Vol 10, No 3 (2014) | RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING | Abstract similar documents |
| V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva | ||
| "... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... in cardiovascular pathology (p=0.034), who have an uncomplicated STEMI upon admission to the hospital, and are sent ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... .8%) and bisoprolol (from 2.4% to 20.3%); in group of angiotensin converting enzyme inhibitors – enalapril (from 3 ..." | ||
| Vol 12, No 6 (2016) | CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE | Abstract similar documents |
| E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto | ||
| "... not receive medical treatment before admission. 34% of patients with HFrEF received ACE inhibitors/angiotensin ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 6, No 6 (2010) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE | Abstract similar documents |
| A. A. Kudryavtsev, A. S. Ryazanov, N. N. Eremenko, S. A. Kireev | ||
| "... Aim. To compare the effects of fixed combinations of angiotensin converting enzyme inhibitor ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... cardiovascular diseases. The atherogenicity of Lp(a) is 6 times higher than that of low-density lipoproteins ..." | ||
| Vol 3, No 1 (2007) | CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA | Abstract similar documents |
| M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva | ||
| "... CHF therapy (angiotensin converting enzyme inhibitors, β-blockers, diuretics, cardiac glycosides ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... 2 (D2) and chronic heart failure (CHF) treated with emangiotensin/em emconverting/em enzyme (ACE) inhibitors ..." | ||
| Vol 21, No 1 (2025) | Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... - emconverting/em enzyme inhibitor /emangiotensin/em II receptor blocker + beta-blocker (BB) + mineralocorticoid receptor ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... Aim. To evaluate in a prospective 10-year follow-up study emcardiovascular/em mortality rate ..." | ||
| Vol 8, No 1 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 | Abstract similar documents |
| V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
| "... among the emcardiovascular/em diseases in the economically developed and developing countries of the world ..." | ||
| 1 - 100 of 755 Items | 1 2 3 4 5 6 7 8 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
